Continual audits, both internally by our quality assurance department, and externally, by the Israel Ministry of Health and our multinational QA teams, assures our partners of utmost integrity when dealing with their pharmaceutical and medical devices. We invest significant resources into the professional treatment of all stock items entrusted to us.
Novolog maintains the highest level of Gxp standards. This includes compliance with
- cGSP – (current Good Storage Practice for medicinal products);
- GDP- guidelines on Good Distribution Practice of medicinal products for human use (94/C 63/03); and
- Local Israeli regulations.
The company is in ongoing validation processes of all its computerized systems, coldrooms, warehouses, and distribution fleet to be positively assured of compliance.
All Novolog's procedures are subjected to a defined system of SOP's which is managed by the Quality Assurance Department. Each employee is re-trained annually as a refresher and to keep up with changing methods and standards.
Novolog works according to a Change Control Management System and has a defined procedure for Deviations Investigations, and also on a scale of Time Perspective (Trending).